#nmpa
Priscilla Block shared that Taylor Swift sent her flowers after she performed a medley of Taylor’s songs at the NMPA awards a few years ago!
November 21, 2026 at 12:21 AM
NMPA asks judges for MLC v. Spotify documents as Amazon seeks lower songwriter rates

#StreamingRoyalties #Spotify #AmazonMusic
NMPA asks judges for MLC v. Spotify documents as Amazon seeks lower songwriter rates
Publishers want bundle evidence in the 2028-2032 rate case, where four services want current terms kept and Amazon wants a 13.4% headline rate.
lockgroove.net
November 22, 2026 at 5:09 PM
NMPA and NSAI Double Down on Their Push to Subpoena MLC v. Spotify Documents Amid Intensifying Phonorecords V Rate-Setting Battle

#mediaor
NMPA Seeks MLC v. Spotify Subpoena Amid Phono V Proceeding
The NMPA and NSAI are attempting to subpoena documents from the MLC v. Spotify legal battle amid the Phonorecords V rate-setting proceeding.
www.digitalmusicnews.com
November 18, 2026 at 7:08 PM
La NMPA y la NSAI redoblan sus esfuerzos para obtener, mediante citación judicial, documentos del caso MLC contra Spotify, en medio de una creciente disputa sobre la fijación de tarifas para fonogramas (Phonorecords V).

www.santananews.com/2026/11/la-n...
La NMPA y la NSAI redoblan sus esfuerzos para obtener, mediante citación judicial, documentos del caso MLC contra Spotify, en medio de una creciente disputa sobre la fijación de tarifas para fonograma...
NMPA redobla la presión en la batalla por las regalías: El caso Spotify podría influir en los pagos a compositores hasta 2032
www.santananews.com
November 20, 2026 at 2:30 AM
Harbour BioMed's Revolutionary AI-Driven Drug LET003 for Obesity Treatment Accepted by NMPA#China#Shanghai#Harbour_BioMed#AI_Drug#LET003
Harbour BioMed's Revolutionary AI-Driven Drug LET003 for Obesity Treatment Accepted by NMPA
Harbour BioMed announces the acceptance of its IND application for LET003, an AI-driven drug aimed at combatting obesity, offering a new path for treatment.
third-news.com
November 19, 2026 at 12:13 AM
Eli Lilly beats Novo in the race to bring an oral GLP-1 weight loss drug to China after the country's regulator approves Foundayo

www.pharmaceutical-technology.com/news/eli-lil...

#pharma
Eli Lilly beats Novo to oral China GLP-1RA market on NMPA approval  - Pharmaceutical Technology
Lilly is the first to get the regulatory OK for an oral weight loss drug in China, as competition in the cardiometabolic market heats up.
www.pharmaceutical-technology.com
November 18, 2026 at 7:02 AM
China Begins Public Consultation on Proposed Amendments Prohibiting Platinum (Nano) and Silver (Nano) as Cosmetic Ingredients
China Begins Public Consultation on Proposed Amendments Prohibiting Platinum (Nano) and Silver (Nano) as Cosmetic Ingredients
On November 9, 2026, China’s National Medical Products Administration (NMPA) National Institutes for Drug Control (NIDC) began a public...
www.jdsupra.com
November 16, 2026 at 4:11 PM
Akeso's Gumokimab Secures Approval for Ankylosing Spondylitis in China#China#Hong_Kong#Akeso#Gumokimab#IL-17A
Akeso's Gumokimab Secures Approval for Ankylosing Spondylitis in China
Akeso's innovative IL-17A monoclonal antibody, Gumokimab, gains NMPA approval to treat active ankylosing spondylitis, enhancing treatment options in China.
third-news.com
November 16, 2026 at 6:29 AM
China Begins Public Consultation on Proposed Amendments Prohibiting Platinum (Nano) and Silver (Nano) as Cosmetic Ingredients
China Begins Public Consultation on Proposed Amendments Prohibiting Platinum (Nano) and Silver (Nano) as Cosmetic Ingredients
On November 9, 2026, China’s National Medical Products Administration (NMPA) National Institutes for Drug Control (NIDC) began a public...
www.jdsupra.com
November 16, 2026 at 4:11 PM
China's NMPA converts Junshi's toripalimab monotherapy for advanced urothelial cancer after platinum failure from conditional to full approval. Basis: mainly Phase 3 RC48-C016, a first-line combo with disitamab vedotin (PFS HR 0.36, OS HR 0.54). https://inlightbio.com/news/?type=policy
November 15, 2026 at 12:30 PM
B&C's Nano and Other Emerging Chemical Technologies Blog: China Begins Public Consultation on Proposed Amendments Prohibiting Platinum (Nano) and Silver (Nano) as Cosmetic Ingredients
www.lawbc.com/china-begins...
#China, #cosmetics, #NIDC, #NMPA, #platinum, #silver
China Begins Public Consultation on Proposed Amendments Prohibiting Platinum (Nano) and Silver (Nano) as Cosmetic Ingredients - Bergeson & Campbell, P.C.
On November 9, 2026, China’s National Medical Products Administration (NMPA) National Institutes for Drug Control (NIDC) began a public consultation on
www.lawbc.com
November 13, 2026 at 10:44 PM
JUST IN: 🇨🇳 CHINA APPROVES HENGRUI SUBSIDIARY'S RIVOCIBART INJECTION - NMPA STATEMENT
X
November 12, 2026 at 6:48 AM
Schemes told to advise specific cohort of members ahead of NMPA change

incm.pub/48RdLty
November 11, 2026 at 3:05 PM
Groundbreaking FDA and NMPA Approval Opens Path for IASO208 CAR-T Therapy in Global Clinical Trials#None#CAR-T_therapy#IASO_Bio#IASO208
Groundbreaking FDA and NMPA Approval Opens Path for IASO208 CAR-T Therapy in Global Clinical Trials
IASO Bio's IASO208 CAR-T therapy recently gained approval from both the FDA and NMPA, propelling forward synchronized clinical trials in the U.S. and China.
third-news.com
November 11, 2026 at 5:15 AM
The award Kyle Busch wanted for years now has his name on it. 👀

Samantha Busch accepted the NMPA Most Popular Driver Award in Miami.

#NASCAR
Read more: https://heavy.com/author/dogliwilberforce/
November 11, 2026 at 1:08 AM
Thank you, for always reminding us we're not alone.
P!NK receives the NMPA Icon Award 2026
YouTube video by P!NK
youtube.com
November 8, 2026 at 3:51 AM
Bio-Thera's BAT2506 Receives NMPA Approval as China's First Golimumab Biosimilar#China#Guangzhou#Bio-Thera#BAT2506#golimumab
Bio-Thera's BAT2506 Receives NMPA Approval as China's First Golimumab Biosimilar
Bio-Thera Solutions announces that its golimumab biosimilar, BAT2506, has gained NMPA approval, a significant milestone for patients in China with autoimmune diseases.
third-news.com
November 6, 2026 at 12:12 PM